
Avis Budget Group Loses Its Turnaround CEO - The Special Situations Report Episode #6
The Special Situations Report
00:00
Potential Acquisition of Springworks Therapeutics by Merck Group
This chapter delves into the rumored acquisition of Springworks Therapeutics by Merck Group, emphasizing the impact of this deal on the company’s stock and product lineup. It also explores Merck’s prior acquisition of Myres Bio and provides insights into the leadership team's expertise at Springworks.
Transcript
Play full episode